자동 및 폐쇄형 세포 치료 처리 시스템 시장 규모, 점유율, 동향 분석 보고서 : 워크플로우별, 유형별, 규모별, 지역별, 부문별 예측(2025-2030년)

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation), By Type (Stem Cell Therapy), By Scale (Commercial Scale), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,609,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,950 ￦ 10,055,000

Printable PDF (5-User License)

PDF 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,950 ￦ 12,949,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

자동 및 폐쇄형 세포 치료 처리 시스템 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 자동 및 폐쇄형 세포 치료 처리 시스템 세계 시장 규모는 2025-2030년 동안 19.8%의 CAGR을 기록하며 2030년까지 41억 2,000만 달러에 달할 것으로 예상됩니다. 시장 기업들은 세포 치료제 개발 프로세스를 가속화하기 위한 실행 가능한 전략으로 자동화된 공정 시스템을 도입하기 위해 많은 투자를 하고 있으며, 이는 시장 성장을 촉진하고 있습니다.

GMP 제조 시설의 확장은 상업적 운영에서 자동화된 프로세스의 도입을 더욱 촉진하고 있습니다. 또한, 일회용 튜브 세트 및 백의 광범위한 적용 범위는 치료 연구 및 개발의 자동화를 촉진하고 있습니다. 또한, 주요 기업들은 제조 실험실에 자동화된 기술을 효과적으로 도입하기 위한 전략을 수립하고 있으며, 이는 수익 성장에 도움이 되고 있습니다.

COVID-19 확진자 급증은 시장 성장에 중요한 역할을 할 것으로 예상됩니다. 팬데믹으로 인해 자동화 기술에 대한 관심이 높아지고 있습니다. 또한, 기업들은 COVID-19와 싸우기 위한 첨단 치료법과 재생의료를 개발하기 위해 자금 조달에 집중하고 있습니다. 업계는 줄기세포 치료, 자연살해세포 치료, 엑소좀과 같은 새로운 치료법 개발에도 집중하고 있습니다.

자동 및 폐쇄형 세포 치료 처리 시스템 시장 보고서 하이라이트

• 분리 부문은 2024년 31.7%의 점유율로 시장을 장악하고 예측 기간 동안 20.7%의 CAGR로 가장 빠르게 성장할 것으로 예상됩니다.
• 비 줄기세포 치료 부문은 2024년 가장 큰 시장 수익 점유율을 차지했으며, 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 사전 상업/연구 개발 규모 부문은 2024년 가장 큰 시장 수익 점유율을 차지했으며, 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 북미 자동 및 폐쇄형 세포 치료 처리 시스템 시장은 2024년 50.1%의 가장 큰 점유율을 차지했습니다. 이는 세포 및 유전자 치료의 보관, 운송 및 처리를 간소화하고 임상 테스트 및 상업화 노력의 효율성을 높이는 통합 솔루션에 대한 수요가 증가하고 있기 때문입니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 자동 및 폐쇄형 세포 치료 처리 시스템 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 자동 및 폐쇄형 세포 치료 처리 시스템 시장 : 워크플로우 비즈니스 분석

• 워크플로우 시장 점유율, 2024년과 2030년
• 워크플로우 부문 대시보드
• 시장 규모와 예측과 동향 분석, 워크플로우별, 2018-2030년
• 분리
• 증식
• 혈액성분채집술
• 충전-마감
• 동결보존
• 기타

제5장 자동 및 폐쇄형 세포 치료 처리 시스템 시장 : 유형 비즈니스 분석

• 유형별 시장 점유율, 2024년과 2030년
• 유형 부문 대시보드
• 시장 규모와 예측과 동향 분석, 유형별, 2018-2030년
• 줄기세포 치료
• 비줄기세포 치료

제6장 자동 및 폐쇄형 세포 치료 처리 시스템 시장 : 규모 비즈니스 분석

• 규모 시장 점유율, 2024년과 2030년
• 규모 부문 대시보드
• 시장 규모와 예측과 동향 분석, 규모별, 2018-2030년
• 프리커머셜/연구개발 규모
• 상업 규모

제7장 자동 및 폐쇄형 세포 치료 처리 시스템 시장 : 워크플로우, 유형, 규모에 의한 국가 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 참여자 개요
• 기업의 시장 포지션 분석
• 기업 분류
• 전략 매핑
• 기업 개요/상장 기업
  • Miltenyi BIoTec
  • Lonza
  • Fresenius Kabi AG
  • Danaher Corporation
  • BioSpherix, LLC
  • Terumo Corporation
  • Sartorius AG
  • ThermoGenesis Holdings, Inc.
  • CELLARES
  • Thermo Fisher Scientific Inc.

ksm

영문 목차

영문목차

Automated And Closed Cell Therapy Processing Systems Market Growth & Trends:

The global automated and closed cell therapy processing systems market size is expected to reach USD 4.12 billion by 2030, registering a CAGR of 19.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market players are making significant investments to introduce an automated process system as a viable strategy to accelerate their cell therapy product development process, thereby driving market growth.

The expansion of GMP manufacturing facilities further supports the implementation of automated processes for commercial operations. In addition, the wide application scope of single-use disposable tubing sets and bags also facilitates automated processing of therapy R&D. Moreover, key entities are undertaking strategies for effective implementation of automation technology in manufacturing labs resulting in lucrative revenue growth.

The rapid growth in the cases of COVID-19 is anticipated to play a vital role in the market growth. The pandemic has led to an increased focus on automation technologies. Moreover, the companies emphasized raising funds with an aim to develop advanced therapies and regenerative medicines to fight against COVID-19. Industry players are also concentrating on the development of new therapies, such as stem cell therapy, natural killer cell therapy, exosomes, and others.

Automated And Closed Cell Therapy Processing Systems Market Report Highlights:

• The separation segment dominated the market and accounted for a share of 31.7% in 2024 and is expected to grow at the fastest CAGR of 20.7% over the forecast period.
• The non stem cell therapy segment accounted for the largest market revenue share in 2024 and is expected to grow at the fastest CAGR over the forecast period.
• The pre-commercial/ R&D scale segment accounted for the largest market revenue share in 2024 and is expected to grow at the fastest CAGR over the forecast period.
• North America automated and closed cell therapy processing systems market held the largest share of 50.1% in 2024 owing to the increasing demand for integrated solutions that streamline the storage, transportation, and processing of cell and gene therapies, enhancing the efficiency of clinical trials and commercialization efforts.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Workflow
  • 1.2.2. Type
  • 1.2.3. Scale
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Automated and Closed Cell Therapy Processing Systems Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Automated and Closed Cell Therapy Processing Systems Market: Workflow Business Analysis

• 4.1. Workflow Market Share, 2024 & 2030
• 4.2. Workflow Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 4.4. Separation
  • 4.4.1. Separation market, 2018 - 2030 (USD Million)
• 4.5. Expansion
  • 4.5.1. Expansion market, 2018 - 2030 (USD Million)
• 4.6. Apheresis
  • 4.6.1. Apheresis market, 2018 - 2030 (USD Million)
• 4.7. Fill- Finish
  • 4.7.1. Fill- Finish market, 2018 - 2030 (USD Million)
• 4.8. Cryopreservation
  • 4.8.1. Cryopreservation market, 2018 - 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Automated and Closed Cell Therapy Processing Systems Market: Type Business Analysis

• 5.1. Type Market Share, 2024 & 2030
• 5.2. Type Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Stem Cell Therapy
  • 5.4.1. Stem cell therapy market, 2018 - 2030 (USD Million)
• 5.5. Non Stem Cell Therapy
  • 5.5.1. Non stem cell therapy market, 2018 - 2030 (USD Million)

Chapter 6. Automated and Closed Cell Therapy Processing Systems Market: Scale Business Analysis

• 6.1. Scale Market Share, 2024 & 2030
• 6.2. Scale Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Scale, 2018 to 2030 (USD Million)
• 6.4. Pre-Commercial/ R&D Scale
  • 6.4.1. Pre-commercial/ R&D scale market, 2018 - 2030 (USD Million)
• 6.5. Commercial Scale
  • 6.5.1. Commercial scale market, 2018 - 2030 (USD Million)

Chapter 7. Automated and Closed Cell Therapy Processing Systems Market: Country Estimates & Trend Analysis by Workflow, Type and Scale

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamic
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. U.S. automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. Canada automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. Mexico automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key country dynamic
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. UK automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. Germany automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. France automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. Italy automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Spain automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Denmark automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key country dynamic
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive insights
    • 7.5.8.4. Sweden automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key country dynamic
    • 7.5.9.2. Regulatory framework
    • 7.5.9.3. Competitive insights
    • 7.5.9.4. Norway automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamic
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Japan automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamic
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. China automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamic
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive insights
    • 7.6.4.4. India automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key country dynamic
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive insights
    • 7.6.5.4. Australia automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamic
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive insights
    • 7.6.6.4. Thailand automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. South Korea
    • 7.6.7.1. Key country dynamic
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive insights
    • 7.6.7.4. South Korea automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamic
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. Brazil automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Argentina automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamic
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive insights
    • 7.8.2.4. South Africa automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamic
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive insights
    • 7.8.3.4. Saudi Arabia automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamic
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive insights
    • 7.8.4.4. UAE automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamic
    • 7.8.5.2. Regulatory framework
    • 7.8.5.3. Competitive insights
    • 7.8.5.4. Kuwait automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Miltenyi Biotec
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Product benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Lonza
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Product benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Fresenius Kabi AG
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Product benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. Danaher Corporation
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Product benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. BioSpherix, LLC
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Product benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. Terumo Corporation
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Product benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. Sartorius AG
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. ThermoGenesis Holdings, Inc.
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. CELLARES
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Thermo Fisher Scientific Inc.
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product benchmarking
    • 8.5.10.4. Strategic initiatives

관련자료